Back to search

Article

Prevalence and Risk Factors of Rifampicin Resistant Mycobacterium Tuberculosis among Human Immune Virus Sero-Positive Patients in South Western Uganda

2023-11-15

Abstract excerpt

<title>Abstract</title> <p>Background Tuberculosis is treated using rifampicin and isoniazid as the first line drugs, with rifampicin playing a pivotal role in the effective treatment of tuberculosis. However, resistance to rifampicin is common and used as a valuable surrogate marker for multi-drug resistant tuberculosis (MDR-TB). Furthermore, HIV co-infection complicates the management of PTB. Methods Across s...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a1055b87-3f46-5017-a5a5-f748d489a61c
DOI
10.21203/rs.3.rs-3486350/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Prevalence and Risk Factors of Rifampicin Resistant Mycobacterium Tuberculosis among Human Immune Virus Sero-Positive Patients in South Western UgandaDOI 10.21203/rs.3.rs-3486350/v1
Select a neighboring publication to make it the new centre.